← The Wire
PLYXNasdaq
Polaryx Therapeutics, Inc.
Pharmaceutical Preparations · WY · CIK 2075320
Developing novel therapies for rare pediatric lysosomal storage diseases
$118M
Market cap
$2.53
Last close
+5.4%
1D
+5.0%
5D
337K
Volume
Price · last 39 sessions-50.6%
May 4L $2.26 · H $5.12Jun 29
7
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Equity IssuanceMay 28, 202610-QQUARTERLY REPORTMay 15, 202610-KANNUAL REPORTMar 24, 2026SC 13DSC 13DFeb 5, 2026424B4PROSPECTUSFeb 2, 2026S-1/AREGISTRATION STATEMENTJan 27, 2026S-1/AREGISTRATION STATEMENTJan 14, 2026S-1REGISTRATION STATEMENTNov 21, 2025
Insider Activity
In the 90 days to Feb 18, 2026: 1 insider bought $8K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Landis G. MichaelChief Financial Officer | Buy | 2,867 | $2.79 | $8K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance